CSNK1A1 and myelodysplastic syndrome: Lenalidomide is also highly effective in myelodysplastic syndrome (MDS) with the deletion of chromosome 5q, where it induces the ubiquitination of casein kinase 1A1 (CK1α) by CRL4CRBN [194].